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Aortic Stenosis: Look Globally, Think Globally*
Philippe Pibarot, DVM, PHD, Jean G. Dumesnil, MD
Québec, CanadaIn the past, calcific aortic valve stenosis (AS) was
thought to be a degenerative process. However,
there is a now a strong body of evidence suggesting
that calcific AS is in fact an active disease akin to
atherosclerosis, and in this context, it is not surpris-
ing that many patients with AS also have manifes-
tations of atherosclerosis in other target organs.
Hence, calcific AS should not be viewed as an
isolated disease strictly limited to the aortic valve
but rather as a systemic disease that often includes
increased rigidity of the aorta caused by atheroscle-
rosis or aging and alterations of left ventricular (LV)
function secondary to coronary artery disease, sys-
temic hypertension, or diabetes. This new face of
See page 390
the disease underlines the need for a more compre-
hensive assessment of AS severity going beyond the
classical measurement of transvalvular pressure gra-
dient and aortic valve area. Given its noninvasive,
radiation-free, low-cost, and highly versatile nature,
Doppler echocardiography is the method of choice
for taking a global look at this complex and multi-
faceted disease. In the SEAS (Simvastatin and
Ezetimibe in Aortic Stenosis) study, Doppler echo-
cardiograms of 1,873 patients with asymptomatic
AS were prospectively obtained in 173 sites and
analyzed in a core laboratory. This database pro-
vides a unique opportunity to depict the current
pattern of calcific AS and to elucidate the determi-
nants of its progression and outcome. The main
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
the authors and do not necessarily represent the views of JACC: Cardio-
vascular Imaging or the American College of Cardiology.
From the Québec Heart and Lung Institute, Department of Medicine,
Laval University, Québec, Canada. This work is supported by research
grants from the Canadian Institutes of Health Research (MOP-57745
and MOP-82873), Ottawa, Canada. Dr. Pibarot holds the Canada
Research Chair in Valvular Heart Diseases, Canadian Institutes of Health
Research, Ottawa, Ontario, Canada.findings of the SEAS substudy published in this
issue of iJACC (1) are: 1) one-third of AS patients
with no symptoms and preserved left ventricular
ejection fraction (LVEF) have an impairment of
systolic myocardial function as reflected by reduced
LV mid-wall shortening; 2) the global, that is,
valvular plus arterial, hemodynamic load as esti-
mated by the valvulo-arterial impedance is the main
determinant of myocardial dysfunction; and 3) one-
third of asymptomatic AS patients have reduced
stroke volume despite preserved LVEF. This pat-
tern, referred to as paradoxical low flow AS by
Hachicha et al. (2), is associated with more pro-
nounced LV concentric remodeling, smaller LV
cavity, increased global LV load, and reduced mid-
wall shortening (Fig. 1). Moreover, these patients
often present with a low transvalvular gradient even
though they have a severe stenosis on the basis of
valve area, and this situation may lead to an under-
estimation of stenosis severity and an underutiliza-
tion of valve replacement (2).
Valvulo-Arterial Impedance:
An Index of Global Hemodynamic Load
As highlighted by recent studies (2,3) including the
one by Cramariuc et al. (1), a large proportion (51%
in the SEAS study) of patients with calcific AS also
have concomitant arterial hypertension. Hence, the
LV of AS patients often faces a double load:
valvular plus arterial and, in these patients, the
occurrence of symptoms and adverse events should
logically be related to the global hemodynamic
burden faced by the ventricle. This global load not
only includes the valvular load but also the pulsatile
and steady components of the arterial load, which
are associated with reduced arterial compliance and
increased vascular resistance, respectively. To assess
the global LV hemodynamic load in AS patients,
we recently proposed a new index easily measured
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401y Doppler echocardiography: the valvulo-arterial
mpedance (Zva), which is the ratio of the estimated
V systolic pressure to the stroke volume indexed
or body size (3). This index in fact represents the
alvular and arterial factors that oppose ventricular
jection by absorbing the mechanical energy devel-
ped by the LV. As confirmed in this article (see
ig. 1 of Cramariuc et al. [1]), myocardial dysfunc-
ion is essentially determined by global LV load and
ence, the LV of a patient with moderate AS and
oncomitant hypertension may face a global hemo-
ynamic load that is equivalent or superior to that
Normal flow AS
End-diastole
End-systole
LVEDV: 115 ml
LVEF: 60%
SV = 70 ml
SVi = 39 ml/m2
AVA = 0.7 cm2
∆Pmean = 45 mmHg
Zva = 4.2 mmHg/ml
Figure 1. Comparison of Typical LV Geometry and Doppler Echo
Aortic Stenosis
AS  aortic valve stenosis; AVA  aortic valve area; LVEDV  left v
tion; SV  stroke volume; SVi  stroke volume index; Zva  valvulof a patient with severe AS and no hypertension. lence, in such a patient myocardial dysfunction
ay develop and/or the patient may become symp-
omatic because of the contribution of concomitant
ypertension to an increased hemodynamic load
nd the calculation of Zva may help to reconcile the
pparent discordance between the moderate steno-
is severity and the symptomatic status. If the Zva is
ow, the symptoms may be related to a concomitant
isease such as coronary artery disease. On the other
and, if the Zva is high, the symptoms could be
aused by the additive effects of a moderate AS and
educed arterial compliance and/or increased vascu-
Paradoxical 
low flow AS
LVEDV: 85 ml
LVEF: 60%
SV = 50 ml
SVi = 28 ml/m2
AVA = 0.7 cm2
∆Pmean = 25 mmHg
Zva = 5.2 mmHg/ml.m-2
diographic Findings in Normal Versus Paradoxical Low Flow
icular end-diastolic volume; LVEF  left ventricular ejection frac-
erial impedance; ∆Pmean  mean transvalvular gradient..m-2
car
entrar resistance.
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402ormal LVEF Does Not Mean
ormal Myocardial Function
he most important and novel finding of the study
y Cramariuc et al. (1) is that 1 of 3 patients with
symptomatic AS and preserved LVEF has a sig-
ificant impairment of myocardial systolic function
s reflected by reduced stress-corrected mid-wall
hortening. This important finding reminds us that
VEF is influenced by both intrinsic myocardial
unction and LV cavity geometry. Hence, for a
imilar extent of intrinsic myocardial shortening,
he LVEF or any parameter based solely on endo-
ardial displacement (e.g., fractional shortening)
ill tend to increase in relation to the extent of LV
oncentric remodeling (4). The LVEF may there-
ore markedly underestimate the extent of myocar-
ial impairment in the presence of LV concentric
emodeling such as is generally the case in AS
atients. Hence, what is normal for an LV with
ormal geometry may be abnormal for an LV with
oncentric remodeling. As highlighted by the re-
ults the SEAS substudy (1), an LVEF 50% as
ell as the absence of symptoms cannot exclude the
resence of intrinsic myocardial dysfunction. These
ndings provide further impetus for the systematic
easurement of LV mid-wall and/or longitudinal
hortening to unmask subclinical myocardial dys-
unction that is often not detected by LVEF (2,4).
hese findings also raise the following provocative
uestion: should we consider early valve replace-
ent in asymptomatic patients with severe AS and
reserved LVEF who present with reduced mid-
all shortening? Pending further studies on this
ssue, exercise stress testing could be contemplated
n these patients to confirm the patient’s symptom-
tic status.
Another important finding of the SEAS sub-
tudy (1) is that the global hemodynamic load
stimated by the Zva is by far the most powerful
eterminant of intrinsic myocardial dysfunction in
symptomatic AS patients. This subclinical and
nsidious alteration of myocardial function may
ventually become irreversible, which could, in turn,
ranslate into increased mortality and morbidity. In
ight of the findings of the SEAS study (1) as well
s of our previous study (3), a value of Zva4.5 mm
g/ml·m2.0 (when using stroke volume indexed
or body surface area in the formula of Zva) or 7.0
m Hg/ml·m2.04 (when using stroke volume in-
exed for height2.04) may be useful to identify
atients who are at high risk for deterioration of
yocardial function. In the present study, Cra- tariuc et al. (1) also proposed a multiparameter
core to predict the presence of myocardial systolic
ysfunction. However, this score brings little addi-
ional predictive value over that provided by Zva
area under the receiver-operator characteristic
urve: 0.87 vs. 0.80) and would certainly be more
omplicated to implement for routine clinical use.
hese findings (1–3) underline the point that the
ain determinant of intrinsic myocardial dysfunc-
ion is the global hemodynamic load faced by the
V, regardless of the origin (valvular and/or arte-
ial) of the load. The next important step in this
egard would now be to determine the usefulness of
he Zva to predict adverse outcomes in asymptom-
tic AS patients.
ormal LVEF Does Not Mean Normal
troke Volume
he data of the SEAS substudy (1) further confirm
he findings of Hachicha et al. (2) showing that
bout one-third of patients with calcific AS have
educed stroke volume (stroke volume/body surface
rea 35 ml/m2 or stroke volume/height2.04 22
l/m2.04) despite preserved LVEF. The reduction
n LV output may, in turn, result in lower than
xpected transvalvular gradients (Fig. 1) and
seudonormalization of peripheral blood pressure
n a large proportion of these patients (1–3). In the
EAS substudy (1), 56% of the low flow AS
atients with severe stenosis defined by an energy
oss index 0.55 cm2/m2 had a mean gradient 30
m Hg. Clinically, this situation is highly insidious
ecause both AS and hypertension may appear less
evere on the basis of the transvalvular gradients and
lood pressure, when in fact these patients have a
igher global hemodynamic load and a more pro-
ounced impairment of intrinsic myocardial func-
ion, consistent with a more advanced stage of the
isease.
Because clinicians generally give more weight to
he gradient than to other parameters, this paradox-
cal low flow pattern often leads to an underestima-
ion of stenosis severity and/or symptoms and
hereby to inappropriate delay of aortic valve re-
lacement (2). Moreover, such patients have a
uch better outcome with aortic valve replacement
han with medical treatment.
It thus follows that the proper identification of
atients with paradoxical low flow is crucial and an
mportant caveat is that measurement errors such as
nderestimation of LV stroke volume could lead
he clinician to erroneously conclude that the pa-
ient has low flow severe AS when, in fact, the AS
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403s only moderate. Fortunately, however, these pa-
ients have a cluster of findings and a more com-
rehensive and integrated evaluation that includes
he calculation of relative wall thickness ratio, LV
imension, stroke volume index, mid-wall radius
hortening, and Zva may help the clinician to
dentify the patients with paradoxical low flow
evere AS (Fig. 1). In case of discordance among
he echocardiographic parameters (e.g., low stroke
olume measured by pulsed wave Doppler in the
V outflow tract in conjunction with a normal/high
V end-diastolic volume and ejection fraction),
easurements should be meticulously verified, and
f the discordance persists, further investigations
sing other diagnostic modalities should be con-
emplated. Proper identification of this entity is
ll the more important because although LVEF is
ithin normal range (50%) and gradient is
elatively low (30 to 35 mm Hg), such patientsgradient severe aortic stenosis despite 291–8.ysfunction or symptoms and should thus be
onitored very closely.
onclusions
ramariuc et al. (1) should be commended for an
mportant study and we certainly concur with them
hat further prospective studies are urgently needed
o determine prognosis and most appropriate treat-
ent in asymptomatic patients presenting with
vidence of high global LV load and intrinsic
yocardial dysfunction.
cknowledgment
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